Suven Pharmaceuticals Ltd Quarterly Results

Gross Sales

402.02

307.15

257.72

230.69

252.93

Excise Duty

0

0

0

0

0

Net Sales

402.02

307.15

257.72

230.69

252.93

Other Operating Income

0

0

0

0

0

Other Income

10.57

15.71

14.12

18.16

17.05

Total Income

412.59

322.86

271.84

248.85

269.98

Total Expenditure

328.46

189.45

153.71

150.76

179.59

PBIDT

84.13

133.41

118.13

98.09

90.4

Interest

5.75

3.33

1.67

1.6

2.3

PBDT

78.38

130.08

116.46

96.49

88.1

Depreciation

26.78

20.35

16.96

13.4

17.25

Minority Interest Before NP

0

0

0

0

0

Tax

3.81

41.6

27.91

20.02

18.55

Deferred Tax

9.06

-15.16

-10.39

2.3

-1.07

Reported Profit After Tax

38.73

83.29

81.98

60.77

53.37

Minority Interest After NP

-3.28

0.41

-0.23

0

0

Net Profit after Minority Interest

42.01

82.88

82.21

60.77

53.37

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

42.01

82.88

82.21

60.77

53.37

EPS (Unit Curr.)

1.65

3.26

3.23

2.39

2.1

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

25.46

25.46

25.46

25.46

25.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.92

43.43

45.83

42.52

35.74

PBDTM(%)

19.49

42.35

45.18

41.82

34.83

PATM(%)

9.63

27.11

31.8

26.34

21.1